#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Cold type haemolytic anaemia Fabry's disease Metabolic disorder Type IIa hyperlipidaemia Malignant glioma Kidney transplant rejection Hepato-lenticular degeneration Fusarium infection Turner's syndrome Keratosis follicular Nasopharyngeal cancer Hairy cell leukaemia Craniocerebral injury Selective polysaccharide antibody deficiency More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Basic Information Congenital generalised lipodystrophy Inclusion body myositis – Life with Disease Mucopolysaccharidosis I – Basic Information Hereditary angioedema – Life with Disease Lysosomal storage disorder – Basic Information Encephalitis autoimmune – Basic Information Focal segmental glomerulosclerosis – Basic Information Pleomorphic leiomyosarcoma – Basic Information Ornithine transcarbamoylase deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buclizine Hydrochloride Entinostat Elezanumab LVT-001 ACICLOVIR SODIUM Interferon Beta-1B Phleum Pratense (225) Crd-4730 Oxitriptan Fludrocortisone Propylene Glycol ROC-101 HYDROCHLORIDE Mva-209-Fsp-B2 Bi 764524 THEOPHYLLINE ANHYDROUS Nystatin Lamotrigine Imiquimod Avelumab Memantine Hydrochloride More therapies…

    Learn about Your Condition

    Restless legs syndrome Endometrial stromal sarcoma Fibromyalgia Kaposi's sarcoma Microscopic polyangiitis Post procedural oedema Rectal cancer Tuberculosis Infectious pleural effusion Chronic hepatic failure Wheezing Sarcoma Tympanic membrane hyperaemia Thyroid disorder Demyelination More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Circulatory and Respiratory Physiological Phenomena

  • Study Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary aspergillosis
    Investigated Drugs:
    • Itraconazole
    • Posaconazole
    • Salbutamol
    France

  • High-dose insulin lispro, potassium chloride and glucose treatment for patients with non‑toxic acute cardiogenic shock

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Insulin Lispro
    • Glucose
    Norway

  • Vasopressin Versus Norepinephrine for Patients with Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Argipressin
    • Noradrenaline Tartrate
    France

  • A Study of High-Concentration Oxygen Treatment in Patients with Heart Failure, Pulmonary Hypertension, and Coronary Microvascular Dysfunction

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoxia
    • Pulmonary hypertension
    • Cardiac failure
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on Reversing Opioid-Induced Breathing Problems Using Naloxone and Nalmefene in Healthy Volunteers and Opioid Users

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • NALMEFENE HYDROCHLORIDE
    • Naloxone Hydrochloride
    • Ondansetron Hydrochloride Dihydrate
    The Netherlands

  • Study on Vascular Dysfunction: Comparing Acetylcholine Chloride and Carbachol for Forearm Blood Flow Evaluation in Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Acetylcholine Chloride
    • CARBACHOL
    Denmark
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!